VKTX

Viking Therapeutics
VKTX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$2.88B
EV
$2.03B
Shares Outstanding
114.27M
Beta
0.83

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$90.61
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Viking Therapeutics, Inc.

gainify
VKTX

Viking Therapeutics, Inc.

VKTX

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist o...

Sector

Healthcare

Industry

Biotechnology

CEO

Lian, Brian

Employees

36

IPO Date

2015-04-28

Headquarters

9920 Pacific Heights Boulevard, Suite 350, San Diego, California, 92121, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved